A clinical field trial of Ingelvac® M. hyo administered to three week old piglets in a herd infected with Mycoplasma hyopneumonia;Vergleichende feldstudie zur wirksamkeit von Ingelvac® M. hyo einem einmalimpfstoff gegen Mycoplasma hyopneumoniae

Tierarztliche Umschau

Volumn 59, Issue 4, 2004, Pages 230-234

  Genzow, M ^a   Zabke, J ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b NONE   (Germany)

Author keywords

Efficacy; Field; Germany; Ingelvac M. hyo comparative; M. hyo pigs; Trial

Indexed keywords

INGELVAC; SODIUM CHLORIDE; STELLAMUNE; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; LUNG INJURY; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PLEURA DISEASE; PREVALENCE; SWINE; TOXICITY; WEANING;

BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA HYOPNEUMONIAE; SUS SCROFA;

EID: 1942441696     PISSN: 00493864     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Kobisch, M., Friis, N. F. (1996): Swine mycoplasmosis. Rev. sci. tech. Off. Int. Epiz. 15, 1569-1605.
2. Maes, D., M. Verdonck, H. Deluyker, A. de Kruif (1996): Enzootic pneumonia in pigs. Vet. Q. 18, 104-1099.
3. Madec, F., M. Kobisch (1982): Bilan lésionnel des poumons des porcs charcutiers à l'abattoir. J. de la Recherche Porcine en France 14, 405-412.
4. Halbur, P. (1999): PRRSV interactions with Strep. Suis and Mycoplasma hyopneumoniae (Swine Disease conference for Swine Practitioners. Iowa State University, 1999, p. 9-17).
5. Kobisch, M., B. Blanchard, M. F. le Potier (1993): Mycoplasma hyopneumoniae infection in pigs: Duration of the disease and resistance to reinfection. Vet. Res. 24, 67-77.
6. Biering-Sorenson, U. (1965): The value of recording disease conditions observed at slaughter houses and disposal plants. Veterinarian (Oxford) 165, 3, 87-97.